• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Evolutionary Genomics

edit

Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company’s proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation.

EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.

Recent Milestones

edit

• 
  Evolutionary Genomics received () in Series A funding. (4/11/08)
  Posted 5/26/09 at 5:40am
• 
  Evolutionary Genomics added Ginny P. Orndorff as President, CEO, Director, and Founder.
  Posted 5/26/09 at 5:28am
• 
  Evolutionary Genomics added Walter Messier as CTO.
  Posted 5/26/09 at 5:28am

Videos

Screenshots

edit

Above: Homepage
Uploaded: 5/26/09

Sources

1. Capital Funding Report [edit]